Ascend Wellness Holdings (AAWH) Income from Continuing Operations (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Income from Continuing Operations of 29493000.0 in Q1 2026, up 39.44% quarter-over-quarter from 48703000.0 in Q4 2025, and down 53.15% on a YoY basis from 62947599.91 in Q1 2025.
Ascend Wellness Holdings (AAWH) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 29493000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 53.15% year-over-year to 29493000.0; the TTM figure through Mar 2026 stood at 128428000.0 (down 49.18% YoY), while the FY2025 annual figure was 118193000.0, down 39.06% from the prior year.
- Income from Continuing Operations was 29493000.0 for Q1 2026 at Ascend Wellness Holdings, up from 48703000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 841000.0 in Q2 2023 to a low of 48703000.0 in Q4 2025.
- Historically, Income from Continuing Operations has averaged 21281941.18 across 5 years, with a median of 19343000.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations surged 103.97% in 2023, then plunged 2690.25% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 15050000.0 in 2022, then slipped by 28.52% to 19343000.0 in 2023, then advanced by 13.19% to 16791000.0 in 2024, then slumped by 190.05% to 48703000.0 in 2025, then jumped by 39.44% to 29493000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 29493000.0 (Q1 2026), 48703000.0 (Q4 2025), and 25825000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -29.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.49 Mn |
| Dec 31, 2025 | -48.70 Mn |
| Sep 30, 2025 | -25.83 Mn |
| Jun 30, 2025 | -24.41 Mn |
| Mar 31, 2025 | -19.26 Mn |
| Dec 31, 2024 | -16.79 Mn |
| Sep 30, 2024 | -28.26 Mn |
| Jun 30, 2024 | -21.78 Mn |
| Mar 31, 2024 | -18.16 Mn |
| Dec 31, 2023 | -19.34 Mn |
| Sep 30, 2023 | -11.24 Mn |
| Jun 30, 2023 | 841,000.00 |
| Mar 31, 2023 | -18.47 Mn |
| Dec 31, 2022 | -15.05 Mn |
| Sep 30, 2022 | -16.86 Mn |
| Jun 30, 2022 | -21.17 Mn |
| Mar 31, 2022 | -27.82 Mn |
| Dec 31, 2021 | -16.51 Mn |
| Sep 30, 2021 | -13.03 Mn |
| Jun 30, 2021 | -44.90 Mn |